Impairment of B cell trafficking and differentiation during HIV-1 infection
Author: Dang, Vu Phuong Linh
Date: 2011-10-27
Location: Hillarpsalen, Retzius väg 8, Karolinska Institutet, Solna.
Time: 09.00
Department: Inst för mikrobiologi, tumör- och cellbiologi / Dept of Microbiology, Tumor and Cell Biology
Abstract
During the course of HIV-1 infection, several B cell dysfunctions occur as result of virus replication and indirect mechanisms of immunopathology. The B cells abnormalities include hypergammaglobulinemia, a decreased number of memory B cells, increased levels of activation markers on B cell surface and plasmacytosis. The molecular bases for these impairments are not fully characterized but may have relevance for designing functional HIV vaccines and improved treatment.
In paper I the expression of chemokine receptors/chemokines important for B cell function was determined on cells from HIV-1 infected patients and controls. We studied the CXC chemokine receptor 4 (CXCR4), CXCR5, and CC chemokine receptor 7 (CCR7) and their respective ligands. We found a decreased expression of CXCR5 to be present on blood B cells from patients (P<0.05), in association with low CD4+ T-cell counts. Interestingly, B cells in blood and lymph nodes from HIV-1-infected patients also displayed an increased expression of the CXC chemokine ligand 13 (CXCL13), the ligand for CXCR5. Upon B-cell activation in vitro, CXCL13 was secreted in culture. The findings suggest that altered CXCR5/CXCL13 expression may participate in B-cell dysfunctions during HIV-1 infection. Loss of memory B cells is a regular finding in the blood of HIV-1 infected patients and the possibility exists that increased apoptosis via the Fas death receptor pathway may participate in this pathological mechanism. Interleukin-7 (IL-7), present to high levels in blood of HIV-1 infected patients, was previously reported to lead to increased Fas expression and Fas mediated apoptosis on T cells.
In paper II, a novel mechanism responsible for increased B cell apoptosis in presence of the high IL-7 concentration was described. T cells cultured with IL-7 induced high Fas expression on resting B cells together with an increased sensitivity to Fas mediated apoptosis. As the mediator responsible for B cell priming to Fas mediated apoptosis we identified the cytokine IFN-γ that T cells secrete in response to IL-7. These results indicate a potential link between IL-7 and the increased B cell apoptosis in HIV-1 infected individuals. During HIV-1 infection, loss of memory B-cells, together with an altered differentiation of naïve B-cells, result in production of low quality antibodies, which may be due to impaired immunoglobulin affinity maturation.
In paper III, we evaluated the effect of HIV-1 infection on class switch recombination and somatic hypermutation, crucial processes for the generation of functional antibodies, by studying the expression of activation-induced cytidine deaminase (AID) in peripheral B-cells from HIV-1 infected patients and healthy controls. We also studied the phenotype of B cells and their ability to produce immunoglobulins in vitro. Cells from HIV-1 infected patients showed higher baseline levels of AID expression and increased IgA production measured ex-vivo and upon CD40 and TLR9 stimulation in vitro. Moreover, the percentage of CD27(-)IgA+ and CD27(-)IgG+ B-cells in blood was significantly increased in HIV-1 infected patients. Interestingly, our results also showed a significantly increased number of somatic hypermutations in the VH genes in CD27(-) cells from patients.
Taken together, the results show that during HIV-1 infection, CD27(-) B-cells can produce class switched and somatically hypermutated antibodies. High levels of soluble CD27 (sCD27), a marker of immune activation, are found during HIV-1 infection; whether sCD27 has a biological role on B cells was previously not known. The aim of paper IV was to investigate whether sCD27, by binding to CD70, can induce IgG production from B cells. B cells from healthy and HIV-1-infected individuals were cultured with recombinant human sCD27 (rhsCD27) and IgG production was measured in culture. We demonstrated that rhsCD27 induced IgG production from antigen-primed (CD27+) B cells. This effect was mediated by rhsCD27 binding to CD70 on B cells leading to activation of Blimp-1 and XBP-1, transcription factors associated with plasma cell differentiation. We found a significant correlation between the levels of serum sCD27 and IgG in HIV-1-infected individuals and healthy controls. The sCD27 may act to enhance immunoglobulin production and differentiation of activated memory B cells, thus providing an activation signal to antigen-experienced B cells. This mechanism may operate during HIV-1 infection when continuous immune activation may lead to up-regulation of CD70 expression and increased sCD27 cleavage and account for increased levels of circulating IgG.
In conclusion, in this PhD thesis different mechanisms leading to impairments of B cell function observed during HIV-1 infection, in parallel to abnormal events of immune activation, are characterized.
In paper I the expression of chemokine receptors/chemokines important for B cell function was determined on cells from HIV-1 infected patients and controls. We studied the CXC chemokine receptor 4 (CXCR4), CXCR5, and CC chemokine receptor 7 (CCR7) and their respective ligands. We found a decreased expression of CXCR5 to be present on blood B cells from patients (P<0.05), in association with low CD4+ T-cell counts. Interestingly, B cells in blood and lymph nodes from HIV-1-infected patients also displayed an increased expression of the CXC chemokine ligand 13 (CXCL13), the ligand for CXCR5. Upon B-cell activation in vitro, CXCL13 was secreted in culture. The findings suggest that altered CXCR5/CXCL13 expression may participate in B-cell dysfunctions during HIV-1 infection. Loss of memory B cells is a regular finding in the blood of HIV-1 infected patients and the possibility exists that increased apoptosis via the Fas death receptor pathway may participate in this pathological mechanism. Interleukin-7 (IL-7), present to high levels in blood of HIV-1 infected patients, was previously reported to lead to increased Fas expression and Fas mediated apoptosis on T cells.
In paper II, a novel mechanism responsible for increased B cell apoptosis in presence of the high IL-7 concentration was described. T cells cultured with IL-7 induced high Fas expression on resting B cells together with an increased sensitivity to Fas mediated apoptosis. As the mediator responsible for B cell priming to Fas mediated apoptosis we identified the cytokine IFN-γ that T cells secrete in response to IL-7. These results indicate a potential link between IL-7 and the increased B cell apoptosis in HIV-1 infected individuals. During HIV-1 infection, loss of memory B-cells, together with an altered differentiation of naïve B-cells, result in production of low quality antibodies, which may be due to impaired immunoglobulin affinity maturation.
In paper III, we evaluated the effect of HIV-1 infection on class switch recombination and somatic hypermutation, crucial processes for the generation of functional antibodies, by studying the expression of activation-induced cytidine deaminase (AID) in peripheral B-cells from HIV-1 infected patients and healthy controls. We also studied the phenotype of B cells and their ability to produce immunoglobulins in vitro. Cells from HIV-1 infected patients showed higher baseline levels of AID expression and increased IgA production measured ex-vivo and upon CD40 and TLR9 stimulation in vitro. Moreover, the percentage of CD27(-)IgA+ and CD27(-)IgG+ B-cells in blood was significantly increased in HIV-1 infected patients. Interestingly, our results also showed a significantly increased number of somatic hypermutations in the VH genes in CD27(-) cells from patients.
Taken together, the results show that during HIV-1 infection, CD27(-) B-cells can produce class switched and somatically hypermutated antibodies. High levels of soluble CD27 (sCD27), a marker of immune activation, are found during HIV-1 infection; whether sCD27 has a biological role on B cells was previously not known. The aim of paper IV was to investigate whether sCD27, by binding to CD70, can induce IgG production from B cells. B cells from healthy and HIV-1-infected individuals were cultured with recombinant human sCD27 (rhsCD27) and IgG production was measured in culture. We demonstrated that rhsCD27 induced IgG production from antigen-primed (CD27+) B cells. This effect was mediated by rhsCD27 binding to CD70 on B cells leading to activation of Blimp-1 and XBP-1, transcription factors associated with plasma cell differentiation. We found a significant correlation between the levels of serum sCD27 and IgG in HIV-1-infected individuals and healthy controls. The sCD27 may act to enhance immunoglobulin production and differentiation of activated memory B cells, thus providing an activation signal to antigen-experienced B cells. This mechanism may operate during HIV-1 infection when continuous immune activation may lead to up-regulation of CD70 expression and increased sCD27 cleavage and account for increased levels of circulating IgG.
In conclusion, in this PhD thesis different mechanisms leading to impairments of B cell function observed during HIV-1 infection, in parallel to abnormal events of immune activation, are characterized.
List of papers:
I. Cagigi A, Mowafi F, Phuong Dang LV, Tenner-Racz K, Atlas A, Grutzmeier S, Racz P, Chiodi F, Nilsson A. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. Blood. 2008 Dec 1;112(12):4401-10.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Sammicheli S, Dang VPL, Hong TP, Vivar N, Ruffin N, Chiodi F and Rethi B. IL-7 promotes CD95-induced apoptosis in B cells via the IFN-γ/STAT1 pathway. [Submitted]
III. Cagigi A, Du L, Dang LV, Grutzmeier S, Atlas A, Chiodi F, Pan-Hammarström Q, Nilsson A. CD27(-) B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infection. PLoS One. 2009;4(5):e5427.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Dang LV, Nilsson A, Ingelman-Sundberg H, Cagigi A, Gelinck LB, Titanji K, De Milito A, Grutzmeier S, Hedlund J, Kroon FP, Chiodi F. Soluble CD27 induces IgG production through activation of antigen-primed B cells. J Intern Med. 2012 Mar;271(3):282-93.
Fulltext (DOI)
Pubmed
I. Cagigi A, Mowafi F, Phuong Dang LV, Tenner-Racz K, Atlas A, Grutzmeier S, Racz P, Chiodi F, Nilsson A. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. Blood. 2008 Dec 1;112(12):4401-10.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Sammicheli S, Dang VPL, Hong TP, Vivar N, Ruffin N, Chiodi F and Rethi B. IL-7 promotes CD95-induced apoptosis in B cells via the IFN-γ/STAT1 pathway. [Submitted]
III. Cagigi A, Du L, Dang LV, Grutzmeier S, Atlas A, Chiodi F, Pan-Hammarström Q, Nilsson A. CD27(-) B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infection. PLoS One. 2009;4(5):e5427.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Dang LV, Nilsson A, Ingelman-Sundberg H, Cagigi A, Gelinck LB, Titanji K, De Milito A, Grutzmeier S, Hedlund J, Kroon FP, Chiodi F. Soluble CD27 induces IgG production through activation of antigen-primed B cells. J Intern Med. 2012 Mar;271(3):282-93.
Fulltext (DOI)
Pubmed
Institution: Karolinska Institutet
Supervisor: Chiodi, Francesca
Issue date: 2011-10-05
Rights:
Publication year: 2011
ISBN: 978-91-7457-494-4
Statistics
Total Visits
Views | |
---|---|
Impairment ...(legacy) | 771 |
Impairment ... | 149 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Impairment ... | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
File Visits
Views | |
---|---|
Thesis_Linh_Dang.pdf(legacy) | 523 |
Thesis_Linh_Dang.pdf | 207 |
Spikblad_Linh_Dang.pdf(legacy) | 204 |
Spikblad_Linh_Dang.pdf | 21 |
Spikblad.pdf.txt(legacy) | 2 |
Linhdangthesis.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 395 |
China | 82 |
Germany | 52 |
Sweden | 48 |
South Korea | 17 |
United Kingdom | 13 |
Russia | 11 |
Vietnam | 10 |
Finland | 8 |
France | 8 |
Top cities views
Views | |
---|---|
Ashburn | 55 |
Romeo | 33 |
Beijing | 31 |
Sunnyvale | 26 |
Shenzhen | 22 |
Kiez | 18 |
Seoul | 14 |
Hanoi | 8 |
London | 8 |
Woodbridge | 7 |